aluates Reports

$ 0.0

Automative

Global Peptide Therapeutics Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-6M14482

Global Peptide Therapeutics Drugs Market Research Report 2023

BUY CHAPTERS

Global Peptide Therapeutics Drugs Market Research Report 2025

Code: QYRE-Auto-6M14482

Report

July 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Eli Lilly

TEVA

Novartis

Astrazeneca plc

AbbVie

Ferring

Merck

Ipsen S A

Sanofi

Novo Nordisk

Takeda

Allergan plc

JNJ

Tarix Pharmaceuticals

Lonza

Peptide Therapeutics Drugs Market Size

The global market for Peptide Therapeutics Drugs was valued at US$ 41210 million in the year 2024 and is projected to reach a revised size of US$ 74720 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Peptide Therapeutics Drugs Market

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics Drugs.

The Peptide Therapeutics Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide Therapeutics Drugs Market Report

Report Metric	Details
Report Name	Peptide Therapeutics Drugs Market
Accounted market size in year	US$ 41210 million
Forecasted market size in 2031	US$ 74720 million
CAGR	9.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Injection Oral Other
Segment by Application	Cancer Metabolic Disorders Central Nervous System Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Eli Lilly, Novo Nordisk, Takeda, Teva, Novartis, AstraZeneca, Ipsen, AbbVie, Allergan, Ferring, Merck, JNJ, Tarix Pharmaceuticals, Lonza
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Therapeutics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide Therapeutics Drugs Market growing?

Ans: The Peptide Therapeutics Drugs Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Peptide Therapeutics Drugs Market size in 2031?

Ans: The Peptide Therapeutics Drugs Market size in 2031 will be US$ 74720 million.

Who are the main players in the Peptide Therapeutics Drugs Market report?

Ans: The main players in the Peptide Therapeutics Drugs Market are Sanofi, Eli Lilly, Novo Nordisk, Takeda, Teva, Novartis, AstraZeneca, Ipsen, AbbVie, Allergan, Ferring, Merck, JNJ, Tarix Pharmaceuticals, Lonza

What are the Application segmentation covered in the Peptide Therapeutics Drugs Market report?

Ans: The Applications covered in the Peptide Therapeutics Drugs Market report are Cancer, Metabolic Disorders, Central Nervous System, Other

What are the Type segmentation covered in the Peptide Therapeutics Drugs Market report?

Ans: The Types covered in the Peptide Therapeutics Drugs Market report are Injection, Oral, Other

Recommended Reports

Disease Therapeutics

Pharmaceutical Services

Cancer & Biotherapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Injection

1.2.3 Oral

1.2.4 Other

1.3 Market by Application

1.3.1 Global Peptide Therapeutics Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Metabolic Disorders

1.3.4 Central Nervous System

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide Therapeutics Drugs Market Perspective (2020-2031)

2.2 Global Peptide Therapeutics Drugs Growth Trends by Region

2.2.1 Global Peptide Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide Therapeutics Drugs Historic Market Size by Region (2020-2025)

2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Region (2026-2031)

2.3 Peptide Therapeutics Drugs Market Dynamics

2.3.1 Peptide Therapeutics Drugs Industry Trends

2.3.2 Peptide Therapeutics Drugs Market Drivers

2.3.3 Peptide Therapeutics Drugs Market Challenges

2.3.4 Peptide Therapeutics Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide Therapeutics Drugs Players by Revenue

3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2020-2025)

3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide Therapeutics Drugs Revenue

3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio

3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2024

3.5 Global Key Players of Peptide Therapeutics Drugs Head office and Area Served

3.6 Global Key Players of Peptide Therapeutics Drugs, Product and Application

3.7 Global Key Players of Peptide Therapeutics Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Therapeutics Drugs Breakdown Data by Type

4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2020-2025)

4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2026-2031)

5 Peptide Therapeutics Drugs Breakdown Data by Application

5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2020-2025)

5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide Therapeutics Drugs Market Size (2020-2031)

6.2 North America Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide Therapeutics Drugs Market Size by Country (2020-2025)

6.4 North America Peptide Therapeutics Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide Therapeutics Drugs Market Size (2020-2031)

7.2 Europe Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide Therapeutics Drugs Market Size by Country (2020-2025)

7.4 Europe Peptide Therapeutics Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide Therapeutics Drugs Market Size (2020-2031)

8.2 Asia-Pacific Peptide Therapeutics Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide Therapeutics Drugs Market Size (2020-2031)

9.2 Latin America Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide Therapeutics Drugs Market Size by Country (2020-2025)

9.4 Latin America Peptide Therapeutics Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide Therapeutics Drugs Market Size (2020-2031)

10.2 Middle East & Africa Peptide Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Peptide Therapeutics Drugs Introduction

11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Details

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Peptide Therapeutics Drugs Introduction

11.2.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.2.5 Eli Lilly Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction

11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Peptide Therapeutics Drugs Introduction

11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Teva

11.5.1 Teva Company Details

11.5.2 Teva Business Overview

11.5.3 Teva Peptide Therapeutics Drugs Introduction

11.5.4 Teva Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.5.5 Teva Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Peptide Therapeutics Drugs Introduction

11.6.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Details

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca Peptide Therapeutics Drugs Introduction

11.7.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.7.5 AstraZeneca Recent Development

11.8 Ipsen

11.8.1 Ipsen Company Details

11.8.2 Ipsen Business Overview

11.8.3 Ipsen Peptide Therapeutics Drugs Introduction

11.8.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.8.5 Ipsen Recent Development

11.9 AbbVie

11.9.1 AbbVie Company Details

11.9.2 AbbVie Business Overview

11.9.3 AbbVie Peptide Therapeutics Drugs Introduction

11.9.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.9.5 AbbVie Recent Development

11.10 Allergan

11.10.1 Allergan Company Details

11.10.2 Allergan Business Overview

11.10.3 Allergan Peptide Therapeutics Drugs Introduction

11.10.4 Allergan Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.10.5 Allergan Recent Development

11.11 Ferring

11.11.1 Ferring Company Details

11.11.2 Ferring Business Overview

11.11.3 Ferring Peptide Therapeutics Drugs Introduction

11.11.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.11.5 Ferring Recent Development

11.12 Merck

11.12.1 Merck Company Details

11.12.2 Merck Business Overview

11.12.3 Merck Peptide Therapeutics Drugs Introduction

11.12.4 Merck Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.12.5 Merck Recent Development

11.13 JNJ

11.13.1 JNJ Company Details

11.13.2 JNJ Business Overview

11.13.3 JNJ Peptide Therapeutics Drugs Introduction

11.13.4 JNJ Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.13.5 JNJ Recent Development

11.14 Tarix Pharmaceuticals

11.14.1 Tarix Pharmaceuticals Company Details

11.14.2 Tarix Pharmaceuticals Business Overview

11.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Introduction

11.14.4 Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.14.5 Tarix Pharmaceuticals Recent Development

11.15 Lonza

11.15.1 Lonza Company Details

11.15.2 Lonza Business Overview

11.15.3 Lonza Peptide Therapeutics Drugs Introduction

11.15.4 Lonza Revenue in Peptide Therapeutics Drugs Business (2020-2025)

11.15.5 Lonza Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eli Lilly

TEVA

Novartis

Astrazeneca plc

AbbVie

Ferring

Merck

Ipsen S A

Sanofi

Novo Nordisk

Takeda

Allergan plc

JNJ

Tarix Pharmaceuticals

Lonza

List of Tables

Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Injection

Table 3. Key Players of Oral

Table 4. Key Players of Other

Table 5. Global Peptide Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peptide Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Peptide Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Peptide Therapeutics Drugs Market Share by Region (2020-2025)

Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Peptide Therapeutics Drugs Market Share by Region (2026-2031)

Table 11. Peptide Therapeutics Drugs Market Trends

Table 12. Peptide Therapeutics Drugs Market Drivers

Table 13. Peptide Therapeutics Drugs Market Challenges

Table 14. Peptide Therapeutics Drugs Market Restraints

Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Peptide Therapeutics Drugs Market Share by Players (2020-2025)

Table 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2024)

Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Peptide Therapeutics Drugs, Headquarters and Area Served

Table 21. Global Key Players of Peptide Therapeutics Drugs, Product and Application

Table 22. Global Key Players of Peptide Therapeutics Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Peptide Therapeutics Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Peptide Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Peptide Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Peptide Therapeutics Drugs Product

Table 50. Sanofi Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 51. Sanofi Recent Development

Table 52. Eli Lilly Company Details

Table 53. Eli Lilly Business Overview

Table 54. Eli Lilly Peptide Therapeutics Drugs Product

Table 55. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 56. Eli Lilly Recent Development

Table 57. Novo Nordisk Company Details

Table 58. Novo Nordisk Business Overview

Table 59. Novo Nordisk Peptide Therapeutics Drugs Product

Table 60. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 61. Novo Nordisk Recent Development

Table 62. Takeda Company Details

Table 63. Takeda Business Overview

Table 64. Takeda Peptide Therapeutics Drugs Product

Table 65. Takeda Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 66. Takeda Recent Development

Table 67. Teva Company Details

Table 68. Teva Business Overview

Table 69. Teva Peptide Therapeutics Drugs Product

Table 70. Teva Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 71. Teva Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis Peptide Therapeutics Drugs Product

Table 75. Novartis Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. AstraZeneca Company Details

Table 78. AstraZeneca Business Overview

Table 79. AstraZeneca Peptide Therapeutics Drugs Product

Table 80. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 81. AstraZeneca Recent Development

Table 82. Ipsen Company Details

Table 83. Ipsen Business Overview

Table 84. Ipsen Peptide Therapeutics Drugs Product

Table 85. Ipsen Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 86. Ipsen Recent Development

Table 87. AbbVie Company Details

Table 88. AbbVie Business Overview

Table 89. AbbVie Peptide Therapeutics Drugs Product

Table 90. AbbVie Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 91. AbbVie Recent Development

Table 92. Allergan Company Details

Table 93. Allergan Business Overview

Table 94. Allergan Peptide Therapeutics Drugs Product

Table 95. Allergan Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 96. Allergan Recent Development

Table 97. Ferring Company Details

Table 98. Ferring Business Overview

Table 99. Ferring Peptide Therapeutics Drugs Product

Table 100. Ferring Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 101. Ferring Recent Development

Table 102. Merck Company Details

Table 103. Merck Business Overview

Table 104. Merck Peptide Therapeutics Drugs Product

Table 105. Merck Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 106. Merck Recent Development

Table 107. JNJ Company Details

Table 108. JNJ Business Overview

Table 109. JNJ Peptide Therapeutics Drugs Product

Table 110. JNJ Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 111. JNJ Recent Development

Table 112. Tarix Pharmaceuticals Company Details

Table 113. Tarix Pharmaceuticals Business Overview

Table 114. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product

Table 115. Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 116. Tarix Pharmaceuticals Recent Development

Table 117. Lonza Company Details

Table 118. Lonza Business Overview

Table 119. Lonza Peptide Therapeutics Drugs Product

Table 120. Lonza Revenue in Peptide Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 121. Lonza Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Peptide Therapeutics Drugs Picture

Figure 2. Global Peptide Therapeutics Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide Therapeutics Drugs Market Share by Type: 2024 VS 2031

Figure 4. Injection Features

Figure 5. Oral Features

Figure 6. Other Features

Figure 7. Global Peptide Therapeutics Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Peptide Therapeutics Drugs Market Share by Application: 2024 VS 2031

Figure 9. Cancer Case Studies

Figure 10. Metabolic Disorders Case Studies

Figure 11. Central Nervous System Case Studies

Figure 12. Other Case Studies

Figure 13. Peptide Therapeutics Drugs Report Years Considered

Figure 14. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Peptide Therapeutics Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Peptide Therapeutics Drugs Market Share by Region: 2024 VS 2031

Figure 17. Global Peptide Therapeutics Drugs Market Share by Players in 2024

Figure 18. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2024

Figure 20. North America Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Peptide Therapeutics Drugs Market Share by Country (2020-2031)

Figure 22. United States Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Peptide Therapeutics Drugs Market Share by Country (2020-2031)

Figure 26. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Peptide Therapeutics Drugs Market Share by Region (2020-2031)

Figure 34. China Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Peptide Therapeutics Drugs Market Share by Country (2020-2031)

Figure 42. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2020-2031)

Figure 46. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Peptide Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 50. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 51. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 52. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 53. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 56. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 57. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 58. Allergan Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 59. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 60. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 61. JNJ Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 62. Tarix Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 63. Lonza Revenue Growth Rate in Peptide Therapeutics Drugs Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Protein and Peptide Therapeutics Market Research Report 2025

Global Injection Peptide Drug Market Research Report 2025

Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Peptide Drugs Market Research Report 2024

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Peptide based Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Building Block Market Insights Forecast to 2030

Global Chemical Synthesis Peptide Drugs Market Research Report 2024

Global Clinical Peptide Market Research Report 2024

Peptide Antibiotics Sterile Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide based Generics Market Research Report 2024

Peptide Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Proteins and Peptides Market Research Report 2025

Peptide Coupling Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Proteins Amino Acids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Synthesis Service Market Insights Forecast to 2030

Global Peptide Synthesis Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions